United States · FDA National Drug Code directory
teriparatide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 47781-652_78a0b591-7cbc-7cd1-1b40-b83f3699c2cf
- Product NDC
- 47781-652
- Form
- INJECTION, SOLUTION
- Composition / generic term
- teriparatide
- Labeler
- Alvogen, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20191114
- Source listing expiry
- 20261231
Source-listed ingredients
- TERIPARATIDE — 250 ug/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (47781-652-89) / 2.24 mL in 1 SYRINGE · 47781-652-89
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →